Original Research
Published on 31 Aug 2022
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients
in Hematologic Malignancies
- 3,151 views
- 4 citations






















